© 2020 MJH Life Sciences and HCPLive. All rights reserved.
Lipid Management
Study Targets Right Alirocumab Dosage for Hypercholesterolemia Patients
August 03, 2020
Article
The most common adverse events were injection-site reactions and headaches.
Model Accurately Predicts Benefit of Lipid-Lowering Therapies
July 30, 2020
Article
The model can simulate treatment benefit over time with time-varying low-density lipoprotein cholesterol.
Treating Combined High Lipoprotein, Inflammation Reduces MACE Risks
July 20, 2020
Article
A secondary ACCELERATE assessment shows a particular set of patients who may benefit from Lp(a)-lowering novel agents.
National Lipid Association Gives Statement on Dyslipidemia Genetic Testing
July 15, 2020
Article
The practice of genetic testing has been useful in clinically addressing found cases of familial hypercholesterolemia, among other conditions, but no clinical practice guidelines currently exist for testing patients with suspected hereditary dyslipidemia.
Concierge Medicine and Cardiac Care During COVID-19
July 15, 2020
Video
What does personalized outpatient care look like for a cardiology institute during the pandemic?
Gestational Hypertension Increases Risk of CVD, CHD But Not Thromboembolism
June 25, 2020
Article
A new systematic review and meta-analysis is shedding light on the impact gestational hypertension can have on future risk of cardiovascular diseases.
HDL Cholesterol Not As Useful for Predicting MI in Minority Patients
June 23, 2020
Article
While often referred to as "Good cholesterol" new research suggests HDL measurements do little for predicting risk of heart attack in Black patients
Tai Chi Improves Mental Well-Being of Patients with Cardiovascular Disease
June 09, 2020
Article
A new study from the University of Arizona is shedding light on the psychological impact of Tai Chi in patients with cardiovascular disease.
Blood Pressure Treatment Adherence Reduces Mortality, Regardless of Frailty
June 08, 2020
Article
A new analysis examines impact of treatment adherence in more than 1.2 million patients.
FDA Approves Ticagrelor DAPT for Patients Without CVD, Stroke History
June 01, 2020
Article
The expanded indication is the first regulatory approval for aspirin plus ticagrelor dual antiplatelet therapy in those with a high risk, but no history of heart attack or stroke.